CN110273025A - A kind of Alon mountain virus PCR detection primer group, kit and application - Google Patents

A kind of Alon mountain virus PCR detection primer group, kit and application Download PDF

Info

Publication number
CN110273025A
CN110273025A CN201910533839.4A CN201910533839A CN110273025A CN 110273025 A CN110273025 A CN 110273025A CN 201910533839 A CN201910533839 A CN 201910533839A CN 110273025 A CN110273025 A CN 110273025A
Authority
CN
China
Prior art keywords
alon
alsv
primer
mountain
pcr detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910533839.4A
Other languages
Chinese (zh)
Inventor
王妮娜
刘全
张浩吉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foshan University
Original Assignee
Foshan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foshan University filed Critical Foshan University
Priority to CN201910533839.4A priority Critical patent/CN110273025A/en
Publication of CN110273025A publication Critical patent/CN110273025A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes

Abstract

The invention belongs to viruses molecule detection technique fields, and in particular to a kind of Alon mountain virus PCR detection primer group, kit and application.The nucleotide sequence of the Alon mountain virus PCR detection primer group is as shown in No.1~3 SEQ ID, and the present invention also provides a kind of kits comprising above-mentioned primer sets.Alon mountain virus PCR detection primer group provided by the invention and kit energy are accurate, quick, sensitivity, specifically detect Alon mountain virus, with rapidly and efficiently, the convenient, high specific of operation, high sensitivity, identification is simple, at low cost, do not need expensive instrument, is suitble to the beneficial effects such as on-site test, foundation for Alon mountain method for detecting virus is laid a good foundation, and has certain application value and realistic meaning.

Description

A kind of Alon mountain virus PCR detection primer group, kit and application
Technical field
The invention belongs to viruses molecule detection technique fields, and in particular to a kind of Alon mountain virus PCR detection primer group, examination Agent box and application.
Background technique
Alon mountain virus (Alongshan virus, ALSV) is a kind of newfound segmented flavivirus, is mainly passed through Tick bites propagation, infected cattle, sheep, people etc..ALSV is upper closely related in evolution with Jingmen ixodism poison, and genome is all divided into four pieces Section, overall length 11350bp, S1 piece segment length's 2995bp encoding flaviviral NS5 sample NSP1 albumen;S3 piece segment length's 2811bp encoding flaviviral NS2b-NS3 sample albumen NSP2;S2 piece segment length 2806bp encodes glycoprotein VP1;S4 piece segment length 2738bp, encoding nuclear proteins VP2 With glycoprotein V P3.The molecular biology for detection of Alon mountain virus is blank at present, this research is proposed to stand a kind of detection Ah The method of Longshan virus.
Summary of the invention
For overcome the deficiencies in the prior art and disadvantage, the primary purpose of the present invention is that providing a kind of Alon mountain virus PCR detection primer group.
Another object of the present invention is to provide the applications of above-mentioned Alon mountain virus PCR detection primer group.
A further object of the present invention is to provide a kind of Alon mountain virus PCR detection kit, which includes above-mentioned Alon mountain virus PCR detection primer group.
Fourth object of the present invention is to provide the application of above-mentioned Alon mountain virus PCR detection kit.
A kind of method that of the invention the 5th is designed to provide PCR detection Alon mountain virus.
The purpose of the invention is achieved by the following technical solution:
A kind of Alon mountain virus PCR detection primer group, include primer ALSV-F1, primer ALSV-R1 and primer ALSV-R2, Its nucleotide sequence is as follows:
Primer ALSV-F1:5 '-GTVTTYGTGCCRGGHCTGAC-3 ';
Primer ALSV-R1:5 '-GTGGABGGRGTTATBAYYCCYTTNG-3 ';
Primer ALSV-R2:5 '-TGGCABGTRTCRAAMACWGCRTC-3 ';
Wherein, V, Y, R, H, B, N, M and W indicate degeneracy base code, V=A/G/C;Y=C/T;R=A/G;H=A/C/ T;B=G/C/T;N=A/T/C/G;M=A/C;W=A/T;
Application of the Alon mountain virus PCR detection primer group in the viral diagnosis of Alon mountain;
Application of the Alon mountain virus PCR detection primer group in the viral diagnosis of Alon mountain does not include the diagnosis of disease Purpose;
A kind of Alon mountain virus PCR detection kit includes above-mentioned Alon mountain virus PCR detection primer group;
The Alon mountain virus PCR detection kit, preferably comprises 10 μM of ALSV-F1,10 μM of ALSV-R1, and 10 μM ALSV-R2,10mM dNTP, 10 × Reaction Buffer, archaeal dna polymerase and deionized water;
Application of the Alon mountain virus PCR detection kit in the viral diagnosis of Alon mountain;
Application of the Alon mountain virus PCR detection kit in the viral diagnosis of Alon mountain does not include the diagnosis of disease Purpose;
A kind of method of PCR detection Alon mountain virus, comprises the following steps:
(1) it extracts the RNA of sample to be tested and reverse transcription is cDNA;
(2) PCR system is prepared, using cDNA made from step (1) as template, with above-mentioned Alon mountain virus PCR detection primer Group or primer ALSV-F1 in above-mentioned Alon mountain virus PCR detection kit and primer ALSV-R1 are amplimer, carry out the One wheel PCR amplification;
(3) PCR system is prepared, the first round PCR product obtained using step (2) amplification is template, with above-mentioned Alon mountain disease Malicious PCR detection primer group or primer ALSV-F1 in above-mentioned Alon mountain virus PCR detection kit and primer ALSV-R2 are to expand Increase primer, carries out the second wheel PCR amplification;
(4) the second wheel PCR product for obtaining step (3) amplification carries out agarose gel electrophoresis detection, goes out at 224bp Existing purpose band, then be determined as the positive, do not occur purpose band at 224bp, be then determined as feminine gender;
PCR system described in step (2), preferably comprises following component:
PCR system described in step (3), preferably comprises following component:
The reaction condition of PCR amplification described in step (2) and step (3) is preferred are as follows: 94 DEG C of initial denaturation 5min;94 DEG C of denaturation 30s, 50 DEG C of annealing 30s, 72 DEG C of extension 30s, totally 10 recycle;94 DEG C of denaturation 30s, 48 DEG C of annealing 30s, 72 DEG C of extension 30s, 25 A circulation;72 DEG C of extension 10min;
It should be pointed out that detection of the invention is for the detection to vitro samples, the direct result of detection is viral Magnitude, and not diagnostic result, the direct purpose of the present invention are not diagnosis, the application and method of primer of the invention, kit It is not belonging to diagnostic method.
The present invention has the following advantages and effects with respect to the prior art:
(1) the present invention provides a kind of Alon mountain virus PCR detection primer group, which can be with specific amplification Alon Mountain conserved viral sequences provide technical support to the Testing and appraisal of Alon mountain virus.
(2) present invention devises two groups of different Alon mountain virus PCR detection primer groups, and compares its detection efficiency, ties Fruit shows that primer sets provided by the present invention have the advantages that accurate energy, quick, sensitivity, specifically detect Alon mountain virus, Foundation for Alon mountain method for detecting virus is laid a good foundation, and has certain application value and realistic meaning.
(3) the present invention provides a kind of Alon mountain virus PCR detection kit, the kit have rapidly and efficiently, operation Convenient, high specific, high sensitivity, identification is simple, at low cost, do not need expensive instrument, is suitble to the beneficial effects such as on-site test.
Detailed description of the invention
Fig. 1 is the electrophoresis result figure of embodiment 1PCR amplification;Wherein, M indicates DNA Marker DL2000,1,2 and N1 table Show that the amplification with primer ALSV-F1, primer ALSV-R1 and primer ALSV-R2,3,4 and N2 indicate to use primer ALSV-N5- The amplification of F1, primer ALSV-N5-F2 and primer ALSV-N5-R1;1 and 3 be same amplification template, and 2 and 4 be same amplification Template, N1 and N2 indicate negative control (deionized water), and arrow is expressed as PCR product.
Fig. 2 is the electrophoresis result figure of 1 multisample PCR amplification of embodiment;Wherein, M indicates DNA Marker DL2000, N table Show negative control (deionized water), 1 and 3 be the amplification of primer ALSV-F1, primer ALSV-R1 and primer ALSV-R2,2 Hes 4 be the amplification of primer ALSV-N5-F1, primer ALSV-N5-F2 and primer ALSV-N5-R1;1 and 2 be same amplification mould Plate, 3 and 4 be same amplification template, and arrow is expressed as PCR product.
Fig. 3 is the electrophoresis result figure of 3PCR of embodiment of the present invention amplification sensitivity;Wherein, M indicates DNA Marker DL2000,1 indicates that primary template 100,2 indicates 10 times of dilutions 10-1, 3 indicate 100 times of dilutions 10-2, 4 indicate 1000 times of dilutions 10-3, 5 indicate 10000 times of dilutions 10-4, 6 indicate 100000 times of dilutions 10-5
Fig. 4 is the electrophoresis result figure of 4PCR of embodiment of the present invention amplification clinical sample;Wherein, M indicates DNA Marker DL2000, N indicate negative control (deionized water), and 1~5 indicates that clinical sample to be measured, arrow are expressed as PCR product.
Fig. 5 is the electrophoresis result figure of 5PCR of embodiment of the present invention amplification clinical sample;Wherein, M indicates DNA Marker DL2000, N1, N2 indicate negative control (deionized water), and 1~15 indicates that clinical sample to be measured, arrow are expressed as PCR product.
Specific embodiment
Present invention will now be described in further detail with reference to the embodiments and the accompanying drawings, but embodiments of the present invention are unlimited In this.
In embodiment, Alon mountain virus (ALSV) is in bibliography (A New Segmented Virus Associated with Human Febrile Illness in China(N Engl J Med 2019;380:2116- 2125.) it is disclosed in);
Russian spring-summer encephalitis virus (TBEV) vaccine strain, japanese encephalitis virus (JEV) vaccine strain are commercially available;
Fever is with thrombocytopenic syndromes viral (SFTSV) in bibliography (The first molecular evidence of severe fever with thrombocytopenia syndrome virus in ticks in Jilin, Northeastern China (Tick Borne Dis.2016,7 (6): 1280-1283.)) in disclose;
Embodiment 1
(1) design of primers: drawn according to Alon mountain virus gene sequence (genebank accession number MH158417) design amplification Object pair: primer ALSV-F1, primer ALSV-R1 and primer ALSV-R2;According to Alon mountain virus gene sequence, (genebank is logged in Number MH158415) second pair of amplimer pair of design: primer ALSV-N5-F1, primer ALSV-N5-F2 and primer ALSV-N5- R1, nucleotide sequence are as follows:
ALSV-F1:5 '-GTVTTYGTGCCRGGHCTGAC-3 ';
ALSV-R1:5 '-GTGGABGGRGTTATBAYYCCYTTNG-3 ';
ALSV-R2:5 '-TGGCABGTRTCRAAMACWGCRTC-3 ';
ALSV-N5-F1:5 '-AGRTCHCTVACSKCTGACCCG-3 ';
ALSV-N5-F2:5 '-CCMSARTGGACRGMRGAGGC-3 ';
ALSV-N5-R1:5 '-TCGATGAGAGCACTCACGAATCTG-3 ';
Wherein, V, Y, R, H, B, N, M, W, S, K indicate to annex base code, V=A/G/C;Y=C/T;R=A/G;H=A/ C/T;B=G/C/T;N=A/T/C/G;M=A/C;W=A/T;S=C/G;K=G/T;
(2) extraction of total serum IgE and the synthesis of cDNA:
1. extracting Alon mountain virus (A New Segmented Virus Associated with using TRIzol method Human Febrile Illness in China(N Engl J Med 2019;380:2116-2125.)) total serum IgE;
2. removal genomic DNA reaction system: 5 × gDNA Eraser Buffer, 2 μ L, gDNA Eraser1 μ L is prepared, 1. 100~1000 μ g of total serum IgE obtained, no RNA enzyme water are supplemented to 10 μ L, 42 DEG C of reaction 2min and are placed on 4 DEG C step;
3. prepare reverse transcription reaction system: step 2. react after 10 μ L, PrimeScript RT Enzyme of reaction solution I 1 μ L, RT Primer Mix of Mix, 4 μ L, 5 × PrimeScript Buffer 4 μ L, no 1 μ L of RNA enzyme water amount to 20 μ L, mix It is even;37 DEG C of heating 15min, 85 DEG C of heating 5s, ice bath at least 1min immediately, is put into -20 DEG C and saves backup later.
(3) PCR system is prepared, using cDNA made from step (2) as template, respectively with primer ALSV-F1 and primer ALSV- R1 and primer ALSV-N5-F1 and primer ALSV-N5-R1 is amplimer, carries out first round PCR amplification, and specific PCR amplification is anti- Answer system as shown in table 1:
1 first round of table pcr amplification reaction system
10×Buffer 2.5μL;
10mM dNTP 0.5μL;
Primer ALSV-F1 (or primer ALSV-N5-F1) 1μL;
Primer ALSV-R1 (or primer ALSV-N5-R1) 1μL;
cDNA 2μL;
Archaeal dna polymerase (Tag enzyme) 0.3μL;
ddH2O Complement to 25 μ L;
First round pcr amplification reaction program: 94 DEG C of initial denaturation 5min;94 DEG C of denaturation 30s, 50 DEG C of annealing 30s, 72 DEG C extend 30s, totally 10 recycle;94 DEG C of denaturation 30s, 48 DEG C of annealing 30s, 72 DEG C of extension 30s, 25 recycle;72 DEG C of extension 10min;
(4) prepare PCR system, using the obtained first round PCR product of step (3) amplification as template, with primer ALSV-F1 with Primer ALSV-R2 and primer ALSV-N5-F2 and primer ALSV-N5-R1 is amplimer, carries out the second wheel PCR amplification;
Table 2 second takes turns pcr amplification reaction system
10×Buffer 2.5μL;
10mM dNTP 0.5μL;
Primer ALSV-F1 (or primer ALSV-N5-F2) 1μL;
Primer ALSV-R2 (or primer ALSV-N5-R1) 1μL;
First round PCR product 2μL;
Archaeal dna polymerase (Tag enzyme) 0.3μL;
ddH2O Complement to 25 μ L;
Second wheel pcr amplification reaction program: 94 DEG C of initial denaturation 5min;94 DEG C of denaturation 30s, 50 DEG C of annealing 30s, 72 DEG C extend 30s, totally 10 recycle;94 DEG C of denaturation 30s, 48 DEG C of annealing 30s, 72 DEG C of extension 30s, 25 recycle;72 DEG C of extension 10min;
(5) PCR reacts amplified production analysis: the second wheel PCR product addition for taking the amplification of 5 μ L steps (4) to obtain respectively contains In 1 (W/V) % Ago-Gel of nucleic acid dye, the electrophoresis 25min under 130V pressure stabilizing, gel imaging system observation amplification item Band.224bp signature band is shown on electrophoretogram using primer ALSV-F1, primer ALSV-R1 and primer ALSV-R2 amplification, 218bp feature is shown on electrophoretogram using primer ALSV-N5-F1, primer ALSV-N5-F2 and primer ALSV-N5-R1 amplification Property band, then determine result for the positive;Such as without any band, then determine result for feminine gender.
As a result as shown in Figure 1, sample No. 1 and No. 2 is existed using primer ALSV-F1, primer ALSV-R1 and primer ALSV-R2 The signature band of Alon mountain virus can be detected at 224bp;Sample No. 3 and No. 4 utilize primer ALSV-N5-F1, primer ALSV-N5-F2 and primer ALSV-N5-R1 cannot detect signature band at 218bp, wherein No. 1 and No. 3 from same The serum sample of one patient, No. 2 and No. 4 serum samples for deriving from the same patient.
The amplification efficiency of above-mentioned two groups of primers is further evaluated using multisample, specific method is same as above.
Wherein, primer ALSV-F1, primer ALSV-R1 and the positive findings of primer ALSV-R2 detection have 9 parts, 8 parts negative, Obtained result and virus purification cultivation results are completely the same, and the positive rate of detection is 100%, and primer ALSV-N5-F1, The positive findings of primer ALSV-N5-F2 and primer ALSV-N5-R1 detection have 3 parts, and 14 parts negative, the positive rate of detection is 33.33%, partial results are shown in Fig. 2, illustrate that the detection effect of primer pair ALSV-F1, ALSV-R1, ALSV-R2 are drawn better than primer pair Object ALSV-N5-F1, primer ALSV-N5-F2 and primer ALSV-N5-R1, by primer ALSV-F1, primer ALSV-R1 and primer ALSV-R2 is the PCR detection primer of invention as this.
2 specific test of embodiment
According to 1 step of embodiment (2) specific steps, Alon mountain virus (ALSV), forest are extracted using TRIzol method respectively Encephalitis viruses (TBEV) vaccine strain, japanese encephalitis virus (JEV) vaccine strain and fever are with thrombocytopenic syndromes virus (SFTSV)(The first molecular evidence of severe fever with thrombocytopenia syndrome virus in ticks in Jilin,Northeastern China(Tick Borne Dis.2016,7(6): Total serum IgE 1280-1283.)), and reverse transcription, obtain cDNA, using cDNA as template, with primer ALSV-F1, primer ALSV-R1 It is amplimer with ALSV-R2, carries out first round PCR amplification and the second wheel PCR amplification, specific pcr amplification reaction system and PCR Amplified reaction program is shown in embodiment 1, wherein negative control is deionized water, and positive control is that Alon mountain is viral (ALSV).
It the results are shown in Table 3, only 224bp signature band can be detected in positive control Alon mountain viral (ALSV), remaining is to be checked Viral sample illustrates that virus PCR detection primer group in Alon mountain provided by the invention has preferable specificity without characteristic bands.
The specific test of 3 Alon mountain virus PCR detection primer of table
Test number Virus to be checked Amplification
1 ALSV +
2 TBEV
3 JEV
4 SFTSV
5 ddH2O
The test of 3 sensitivity of embodiment
Alon mountain virus (ALSV) cDNA for being 100ng/ μ L by concentration made from embodiment 2, does 10 times of dilutions, is followed successively by 100、10-1、10-2、10-3、10-4With 10-5, using primer ALSV-F1, primer ALSV-R1 and ALSV-R2 as amplimer, carry out the One wheel PCR amplification and the second wheel PCR amplification, specific pcr amplification reaction system and pcr amplification reaction program are shown in embodiment 1, In, negative control is deionized water, detects the Monitoring lower-cut of PCR primer provided by the present invention.
As a result as shown in figure 3,10-3Purpose band, that is, minimum detectable 100pg/ μ L also can be detected in dilution CDNA template.
The detection of 4 clinical sample of embodiment
5 parts of doubtful Alon mountain virus infection clinical samples are acquired, all samples all pass through cell culture and carry out virus purification. Using method described in embodiment 1, PCR detection is carried out to all samples, as a result as shown in figure 4, in 5 parts of clinical samples, Ah The positive findings of Longshan virus PCR detection have 1 part, 4 parts negative, obtained result and virus purification cultivation results complete one It causes.
The detection of 5 clinical sample of embodiment
15 parts of doubtful Alon mountain virus infection clinical samples are acquired, all samples all carry out virus point by cell culture From.Using method described in embodiment 1, PCR detection is carried out to all samples, as a result as shown in figure 5, in 15 parts of clinical samples In, the positive findings of Alon mountain virus PCR detection have 8 parts, and 7 parts negative, obtained result and virus purification cultivation results are complete It is complete consistent.
The above embodiment is a preferred embodiment of the present invention, but embodiments of the present invention are not by above-described embodiment Limitation, other any changes, modifications, substitutions, combinations, simplifications made without departing from the spirit and principles of the present invention, It should be equivalent substitute mode, be included within the scope of the present invention.
SEQUENCE LISTING
<110>Foshan Science &. Technology College
<120>a kind of Alon mountain virus PCR detection primer group, kit and application
<130> 1
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 20
<212> DNA
<213> Artificial
<220>
<223>primer ALSV-F1
<400> 1
gtvttygtgc crgghctgac 20
<210> 2
<211> 25
<212> DNA
<213> Artificial
<220>
<223>primer ALSV-R1
<220>
<221> misc_feature
<222> (24)..(24)
<223> n is a, c, g, or t
<400> 2
gtggabggrg ttatbayycc yttng 25
<210> 3
<211> 23
<212> DNA
<213> Artificial
<220>
<223>primer ALSV-R2
<400> 3
tggcabgtrt craamacwgc rtc 23
<210> 4
<211> 21
<212> DNA
<213> Artificial
<220>
<223>primer ALSV-N5-F1
<400> 4
agrtchctva cskctgaccc g 21
<210> 5
<211> 20
<212> DNA
<213> Artificial
<220>
<223>primer ALSV-N5-F2
<400> 5
ccmsartgga crgmrgaggc 20
<210> 6
<211> 24
<212> DNA
<213> Artificial
<220>
<223>primer ALSV-N5-R1
<400> 6
tcgatgagag cactcacgaa tctg 24

Claims (9)

1. a kind of Alon mountain virus PCR detection primer group, it is characterised in that include primer ALSV-F1, primer ALSV-R1 and primer ALSV-R2, nucleotide sequence are as follows:
Primer ALSV-F1:5 '-GTVTTYGTGCCRGGHCTGAC-3 ';
Primer ALSV-R1:5 '-GTGGABGGRGTTATBAYYCCYTTNG-3 ';
Primer ALSV-R2:5 '-TGGCABGTRTCRAAMACWGCRTC-3 ';
Wherein, V, Y, R, H, B, N, M and W indicate degeneracy base code, V=A/G/C;Y=C/T;R=A/G;H=A/C/T;B= G/C/T;N=A/T/C/G;M=A/C;W=A/T.
2. application of the Alon mountain virus PCR detection primer group described in claim 1 in the viral diagnosis of Alon mountain.
3. a kind of Alon mountain virus PCR detection kit, it is characterised in that include Alon mountain described in claim 1 virus PCR Detection primer group.
4. Alon mountain virus PCR detection kit according to claim 3, it is characterised in that comprising 10 μM of ALSV-F1, 10 μM of ALSV-R1,10 μM of ALSV-R2,10mM dNTP, 10 × Reaction Buffer, archaeal dna polymerase and deionized water.
5. application of the Alon mountain virus PCR detection kit in the viral diagnosis of Alon mountain described in claim 3 or 4.
6. a kind of method of PCR detection Alon mountain virus, characterized by comprising the steps of:
(1) it extracts the RNA of sample to be tested and reverse transcription is cDNA;
(2) prepare PCR system, using cDNA made from step (1) as template, with above-mentioned Alon mountain virus PCR detection primer group or Primer ALSV-F1 and primer ALSV-R1 in above-mentioned Alon mountain virus PCR detection kit are amplimer, carry out the first round PCR amplification;
(3) PCR system is prepared, the first round PCR product obtained using step (2) amplification is template, with above-mentioned Alon mountain virus PCR Detection primer group or primer ALSV-F1 in above-mentioned Alon mountain virus PCR detection kit and primer ALSV-R2 are that amplification is drawn Object carries out the second wheel PCR amplification;
(4) the second wheel PCR product for obtaining step (3) amplification carries out agarose gel electrophoresis detection, occurs mesh at 224bp Band, then be determined as the positive, do not occur purpose band at 224bp, be then determined as feminine gender.
7. the method for PCR detection Alon mountain virus according to claim 6, it is characterised in that:
PCR system described in step (2) includes following component:
8. the method for PCR detection Alon mountain virus according to claim 6, it is characterised in that:
PCR system described in step (3) includes following component:
9. the method for PCR detection Alon mountain virus according to claim 6, it is characterised in that:
The reaction condition of PCR amplification described in step (2) and step (3) are as follows: 94 DEG C of initial denaturation 5min;94 DEG C of denaturation 30s, 50 DEG C Anneal 30s, 72 DEG C of extension 30s, totally 10 circulations;94 DEG C of denaturation 30s, 48 DEG C of annealing 30s, 72 DEG C of extension 30s, 25 recycle; 72 DEG C of extension 10min.
CN201910533839.4A 2019-06-19 2019-06-19 A kind of Alon mountain virus PCR detection primer group, kit and application Pending CN110273025A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910533839.4A CN110273025A (en) 2019-06-19 2019-06-19 A kind of Alon mountain virus PCR detection primer group, kit and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910533839.4A CN110273025A (en) 2019-06-19 2019-06-19 A kind of Alon mountain virus PCR detection primer group, kit and application

Publications (1)

Publication Number Publication Date
CN110273025A true CN110273025A (en) 2019-09-24

Family

ID=67961121

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910533839.4A Pending CN110273025A (en) 2019-06-19 2019-06-19 A kind of Alon mountain virus PCR detection primer group, kit and application

Country Status (1)

Country Link
CN (1) CN110273025A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113604612A (en) * 2021-09-03 2021-11-05 广东方道基因生物科技有限公司 Alongshan virus loop-mediated isothermal amplification detection primer group, kit containing primer group and application of kit

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140127671A1 (en) * 2011-02-18 2014-05-08 Lg Life Sciences, Ltd. Simultaneous Diagnosis Kit For a Disease Due to a Respiratory Virus
US20160145698A1 (en) * 2014-11-21 2016-05-26 Integrated Dna Technologies, Inc. Primers and probes for detection and discrimination of ebola virus
CN106544449A (en) * 2017-01-12 2017-03-29 中国人民解放军军事医学科学院微生物流行病研究所 A kind of yellow fever virus detection kit and its application based on RPA technologies

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140127671A1 (en) * 2011-02-18 2014-05-08 Lg Life Sciences, Ltd. Simultaneous Diagnosis Kit For a Disease Due to a Respiratory Virus
US20160145698A1 (en) * 2014-11-21 2016-05-26 Integrated Dna Technologies, Inc. Primers and probes for detection and discrimination of ebola virus
CN106544449A (en) * 2017-01-12 2017-03-29 中国人民解放军军事医学科学院微生物流行病研究所 A kind of yellow fever virus detection kit and its application based on RPA technologies

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZE-DONG WANG等: "A New Segmented Virus Associated with Human Febrile Illness in China", 《THE NEW ENGLAND JOURNAL O F MEDICINE》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113604612A (en) * 2021-09-03 2021-11-05 广东方道基因生物科技有限公司 Alongshan virus loop-mediated isothermal amplification detection primer group, kit containing primer group and application of kit
CN113604612B (en) * 2021-09-03 2023-08-01 广东方道基因生物科技有限公司 Aronia virus loop-mediated isothermal amplification detection primer set, kit containing primer set and application of kit

Similar Documents

Publication Publication Date Title
CN106947838B (en) African swine fever virus non-structural gene real-time fluorescence LAMP (loop-mediated isothermal amplification) detection primer group, kit and detection method
CN106801109B (en) RT-PCR detection specific primer, kit and detection method for swine atypical pestivirus
CN108950069A (en) Ox lumpy skin disease virus street strain TaqMan-MGB real-time fluorescence quantitative PCR detection primer, kit and detection method
CN107034313A (en) The RT PCR detection primers and RT PCR detection methods of a pair of Sai Nika paddy virus
CN105018485A (en) Primer and probe for detecting peste des petits ruminants virus by virtue of RPA (Recombinase Polymerase Amplification) technique
CN105567872A (en) RT-RPA detection reagent kit for quickly detecting pest des petits ruminant viruses and application thereof
CN106167837A (en) The real-time fluorescence quantitative PCR detection kit of bovine viral diarrhoea bovine diarrhoea virus and primer special thereof and probe
CN108220483A (en) A kind of reagent, detection method and application for Tilapia mossambica lake viral diagnosis
CN108315444A (en) A kind of multiple PCR primer and discrimination method differentiating layer of green-shell egg genotype
CN103173568B (en) Primer group, kit and method for rapidly identifying 1 type dengue fever virus
CN107164558A (en) A kind of recombinase normal temperature amplification of nucleic acid of Japanese Type-B encephalitis(RT‑RPA)ELISA test strip kit and application
CN106119423A (en) The general PCR primer of detection Avianreovirus and detection kit thereof
CN102399910A (en) Primers and method for identifying swine fever virus vaccine strains and wild strains
CN110273025A (en) A kind of Alon mountain virus PCR detection primer group, kit and application
CN103667531A (en) FQ-PCR detection method for swine epidemic diarrhea virus (PEDV) and primer pair used therein
CN103993089B (en) A kind of multiple fluorescence quantitative PCR detection kit and detection method thereof of vancomycin-resistant enterococcus
CN101892321B (en) Degenerate primer and detection kit for detecting avian paramyxoviruses
CN108060272A (en) A kind of quick differentiation pig Delta coronavirus and the multiple PCR detection primer group and kit of pig ridge virus
CN102108420B (en) Fluorescence quantitative polymerase chain reaction (PCR) kit for detecting dengue virus type 1
CN113637778B (en) Kit and method for detecting brucella
CN107267666A (en) A kind of fluorescent quantitation RT PCR detection kits based on pig atypia pestivirus raq gene
CN109439799A (en) It is a kind of for detecting the sleeve type PCR primer and kit of pig acute diarrhea coronavirus
CN105132583A (en) Influenza virus carried HCV nucleic acid test quality control product and preparation method thereof
CN107254551A (en) A kind of method identified with seed selection PERV pol gene defection type Inbreding Wuzhishan pig new lines
CN107988429B (en) Reagent for detecting rabies virus and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination